International Patent: COMBINATIONS OF KRAS G12C INHIBITOR, EGFR INHIBITOR AND SOS1 INHIBITOR

GENEVA, Nov. 6 -- MIRATI THERAPEUTICS, INC. filed a patent application (US2026/026203) for “COMBINATIONS OF KRAS G12C INHIBITOR, EGFR INHIBITOR AND SOS1 INHIBITOR”. With publication no. WO/2026/232023... Read More

International Patent: COMBINATIONS OF BRAF INHIBITOR, EGFR INHIBITOR AND SOS1 INHIBITOR

GENEVA, Nov. 6 -- MIRATI THERAPEUTICS, INC. filed a patent application (US2026/026205) for “COMBINATIONS OF BRAF INHIBITOR, EGFR INHIBITOR AND SOS1 INHIBITOR”. With publication no. WO/2026/232024, her... Read More

International Patent: SUBSTITUTED HETEROARYLATED PYRROLIDINE-CONTAINING FUSED BICYCLIC SATURATED DIAMINE COMPOUNDS

GENEVA, Nov. 6 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/026190) for “SUBSTITUTED HETEROARYLATED PYRROLIDINE-CONTAINING FUSED BICYCLIC SATURATED DIAMINE COMPOUNDS”. With publi... Read More

International Patent: SUBSTITUTED HETEROARYLATED DIAZABICYCLOOCTANE AND OCTAHYDRONAPHTHYRIDINE COMPOUNDS

GENEVA, Nov. 6 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/026192) for “SUBSTITUTED HETEROARYLATED DIAZABICYCLOOCTANE AND OCTAHYDRONAPHTHYRIDINE COMPOUNDS”. With publication no.... Read More

International Patent: SUBSTITUTED HETEROARYLATED SPIROCYCLIC DIAMINE COMPOUNDS

GENEVA, Nov. 6 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/026193) for “SUBSTITUTED HETEROARYLATED SPIROCYCLIC DIAMINE COMPOUNDS”. With publication no. WO/2026/232020, here are ... Read More

International Patent: FEEDBACK ABSENCE AND TYPE INDICATION

GENEVA, Nov. 6 -- QUALCOMM INCORPORATED filed a patent application (US2026/026180) for “FEEDBACK ABSENCE AND TYPE INDICATION”. With publication no. WO/2026/232014, here are the other details related t... Read More

International Patent: COMPOSITIONS INCLUDING FCRN INHIBITORS AND METHODS OF USING THE SAME IN IMMUNO-BASED DIAGNOSTICS AND THERAPIES

GENEVA, Nov. 6 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2026/026184) for “COMPOSITIONS INCLUDING FCRN INHIBITORS AND METHODS OF USING THE SAME IN IMMUNO-BASED DIAGNOSTIC... Read More

International Patent: SUBSTITUTED HETEROARYLATED PIPERAZINE COMPOUNDS

GENEVA, Nov. 6 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2026/026189) for “SUBSTITUTED HETEROARYLATED PIPERAZINE COMPOUNDS”. With publication no. WO/2026/232017, here are the other... Read More

International Patent: ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING

GENEVA, Nov. 6 -- TEMPUS AI, INC. filed a patent application (US2026/026176) for “ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING”. With publication no. WO... Read More

International Patent: SYSTEMS AND METHODS FOR BIOLOGICAL SALVAGE OF TOXICITY LIMITED OR FAILED THERAPIES

GENEVA, Nov. 6 -- EXIR, INC. filed a patent application (US2026/026178) for “SYSTEMS AND METHODS FOR BIOLOGICAL SALVAGE OF TOXICITY LIMITED OR FAILED THERAPIES”. With publication no. WO/2026/232012, h... Read More

• ««
• «
• 5334
• 5335
• 5336
• 5337
• 5338
• 5339
• 5340
• 5341
• 5342
• 5343
• »
• »»